1090 completed, 491 unknown, 379 recruiting, 166 terminated. 772 Not applicable, 621 Phase 2, 402 Phase 1, 227 Phase 3, 50 Phase 4.
Follow this condition Literature Review of Uterine Cervical Diseases trials Research Report on Uterine Cervical Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV) Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections | Not applicable | Not yet recruiting | Hifas da Terra S.L. | 81 | 2027-07-01 | 2026-10-05 |
| Development of Systems and Education for Cervical Cancer Prevention (DOSE-CC) DOSE-CC Intervention: Educational Sessions - Cervical Cancer Screening, Cervical Cancer | Not applicable | Not yet recruiting | Boston Medical Center | 80000 | 2027-05-01 | 2025-11-10 |
| Topical Curcumin for HPV Related Cervical Disease Curcumin C3 Complex, Placebo - Neoplasm Cervix | Phase 2 | Not yet recruiting | Lisa Flowers | 200 | 2027-04-01 | 2026-05-08 |
| Cancer Awareness Among Syrian Migrants PMT-Based Cancer Screening Educational Intervention, PMT-Based Cancer Screening Education Program - Breast Cancer Screening, Cervical Cancer Screening | Not applicable | Not yet recruiting | Toros University | 30 | 2027-03-09 | 2026-10-15 |
| Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health. Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus | Phase 4 | Not yet recruiting | Eunice Dube | 2140 | 2027-01-30 | 2026-07-30 |
| My Self-Sampling for HPV Awareness, Results, and Empowerment MySHARE+ mHealth Education Intervention, Healthcare Provider Prompt - Cervical Cancer, Cervical Cancer Screening | Not applicable | Not yet recruiting | Daisy Le | 130 | 2027-01-01 | 2026-08-18 |
| Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer Telaglenastat, Radiation treatment, Cisplatin - Advanced Cervical Carcinoma, Cervical Cancer | Phase 2 | Not yet recruiting | Washington University School of Medicine | 42 | 2026-12-31 | 2026-09-03 |
| Vaginal Dose De-escalation During Brachytherapy for Cervical Cancer radiation dose de-escalation - Cervical Cancer | Not applicable | Not yet recruiting | Duke University | 20 | 2026-12-01 | 2026-10-02 |
| COQ10 and Vitamin E for Off-Target Radiation Toxicity Coenzyme Q10 Cap/Tab, Vitamin E Cap/Tab - Prostate Cancer, Uterine Cancer | Phase 1 / Phase 2 | Not yet recruiting | University of Nebraska | 200 | 2026-12-01 | 2026-10-08 |
| Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8 | Phase 2 | Not yet recruiting | Fred Hutchinson Cancer Center | 50 | 2026-12-01 | 2026-09-17 |
| C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States Qualitative interviews, Focus groups - Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV) | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 3500 | 2026-11-10 | 2026-10-20 | |
| Tucatinib Continuation Study tucatinib - HER2-positive Breast Cancer, Cervical Cancer | Phase 4 | Not yet recruiting | Pfizer | 175 | 2026-11-06 | 2026-08-28 |
| A Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44) Pembrolizumab, Cisplatin, 5-Fluorouracil - Neoplasm Malignant, Gastric Neoplasms | Phase 4 | Not yet recruiting | Merck Sharp & Dohme LLC | 150 | 2026-11-06 | 2026-09-03 |
| Breast and Cervical Cancer Stigma in Rwanda Behavioral: RISE Intervention, Behavioral: CHW Educational Intervention - Breast Cancer, Cervical Cancer | Not applicable | Not yet recruiting | Dana-Farber Cancer Institute | 1116 | 2026-11-01 | 2026-06-23 |
| Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing Web-Based Health Education - Cervical Cancer, HPV | Not applicable | Not yet recruiting | Sakarya University | 120 | 2026-11-01 | 2026-09-22 |
| Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 300 | 2026-10-15 | 2026-10-19 |
| Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 200 | 2026-10-15 | 2026-10-20 |
| Feasibility Study Comparing One vs Two Probes for TA Among Cervical Cancer Screen Positive WLWH in C1001P-CS5 Rwanda Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 300 | 2026-10-15 | 2026-10-19 |
| Cervical Cancer Awareness Education to Aid Confidence and Screening upTake (ACT): A Pilot Randomised Control Trial cervical cancer Awareness education to aid Confidence and screening upTake (ACT), Control group - Anxiety, Cervical Cancer Screening | Not applicable | Not yet recruiting | Teesside University | 76 | 2026-10-12 | 2026-10-07 |
| Feasibility Study Comparing Use of One Or Two Probes for Thermal Ablation Among Screen Positive Women Living With HIV in C1001P-CS2 Kenya Thermal ablation (TA) with 1 probe, Thermal ablation (TA) with 2 probes - HIV (Human Immunodeficiency Virus), HPV | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 300 | 2026-10-12 | 2026-10-20 |
Showing 20 of 2510. Sign in to see all of them.
Uterine Cervical Neoplasms (2240) · Uterine Cervical Dysplasia (383) · Endometrial Neoplasms (327) · Ovarian Neoplasms (320) · Breast Neoplasms (219) · Papillomavirus Infections (199) · Vulvar Neoplasms (157) · Carcinoma, Non-Small-Cell Lung (153) · Neoplasms (153) · Vaginal Neoplasms (140) · Stomach Neoplasms (135) · Colorectal Neoplasms (130) · Esophageal Neoplasms (123) · Prostatic Neoplasms (116) · Urinary Bladder Neoplasms (116)
Female Urogenital Diseases (2509) · Female Urogenital Diseases and Pregnancy Complications (2508) · Genital Diseases (2508) · Urogenital Diseases (2508) · Genital Diseases, Female (2500) · Uterine Diseases (2500) · Neoplasms (2308) · Neoplasms by Site (2233) · Urogenital Neoplasms (2231) · Genital Neoplasms, Female (2220) · Uterine Neoplasms (2140) · Pathological Conditions, Signs and Symptoms (502) · Pathologic Processes (411) · Endocrine System Diseases (400)
Cisplatin (187) · Paclitaxel (84) · Radiotherapy (82) · Brachytherapy (75) · Carboplatin (75) · pembrolizumab (69) · Bevacizumab (42) · Colposcopy (34) · Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (33) · Gemcitabine (30) · Surveys and Questionnaires (29) · Topotecan (29) · Radiation (28) · Blood Specimen Collection (25) · human papillomavirus vaccine, L1 type 16, 18 (25)
National Cancer Institute (NCI) (74) · M.D. Anderson Cancer Center (57) · Gynecologic Oncology Group (46) · GlaxoSmithKline (42) · Merck Sharp & Dohme LLC (30) · Peking Union Medical College Hospital (28) · Tata Memorial Hospital (27) · Lei Li (23) · UNC Lineberger Comprehensive Cancer Center (22) · University of Aarhus (22) · Duke University (19) · Huazhong University of Science and Technology (19) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (18) · Sun Yat-sen University (18) · University Health Network, Toronto (18)
United States (883) · China (442) · France (155) · Canada (140) · Italy (103) · South Korea (98) · United Kingdom (97) · Spain (92) · Germany (83) · Taiwan (74) · Belgium (67) · Australia (63) · India (61) · Netherlands (57) · Brazil (55)
Lei Li, M.D. (18) · Michele Follen, MD, PhD (9) · Kathleen Schmeler, MD (7) · Rachel L Winer, PhD, MPH (7) · Michael Milosevic, MD (6) · Ting Wu, Ph. D. (6) · Ziad Hilal, M.D. (6) · Chi-An Chen, MD (5) · Ding Ma, MD, PhD (5) · Anthony Fyles, MD (4)
PMID 41276263, PMID 30380365, PMID 32779730, PMID 41166720, PMID 19236277, PMID 19236279, PMID 19935017, PMID 21444871, PMID 22914404, PMID 27422279, PMID 30982556, PMID 31824976, PMID 32184277, PMID 37496366, PMID 37650664, PMID 41044356, PMID 19586656, PMID 19949018, PMID 20949623, PMID 21471141, PMID 21840137, PMID 21841155, PMID 21907959, PMID 22002018, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23489374, PMID 23632723, PMID 23843155, PMID 24201682, PMID 24435414, PMID 24807330, PMID 25071111, PMID 25207403, PMID 26348120, PMID 26438146, PMID 27319286, PMID 27432417, PMID 28173776, PMID 29074187, PMID 29211620, PMID 29269325, PMID 29767739, PMID 29995724, PMID 30195193, PMID 32161969, PMID 32894896, PMID 33326342, PMID 33794207
U10CA027469 (25), 2023 (21), 2019 (14), U10CA180868 (13), 2018 (11), U24CA275417 (9), 2009 (7), 2017 (7), 2008 (6), 2015 (6), P30CA016672 (6), 2014 (5), 2016 (5), P30CA033572 (5), P30CA043703 (5)